The Aga Khan University, Stadium Road
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hamid, Saeed S
D-LIVR, NCT03719313 / 2018-003167-54: Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a

Completed
3
407
Europe, Canada, US, RoW
Lonafarnib, EBP994, Sarasar, LNF, Ritonavir, Norvir, RTV, PEG IFN-alfa-2a, Pegasys, pegylated interferon-alfa, Placebo Lonafarnib, Placebo Ritonavir
Eiger BioPharmaceuticals
Hepatitis Delta Virus
10/22
03/23
NCT04971538: HCV Self-testing in Pakistan

Recruiting
N/A
2000
RoW
OraQuick® HCV Self-Test
Foundation for Innovative New Diagnostics, Switzerland, Aga Khan University
Hepatitis C, Diagnostic Self Evaluation
03/22
04/22
NCT04943588: Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

Recruiting
N/A
25000
RoW
HCV RNA (PCR), HCV Antibody test (Point of care), AST/ALT and platelets measurement
Queen Mary University of London, Aga Khan University, Dow University of Health Sciences, University of Oxford, University of Bristol
Hepatitis C, Chronic
11/24
01/25
NCT05248919: Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan

Enrolling by invitation
N/A
318
RoW
Epclusa (nucleotide HCV NS5B polymerase inhibitors)., Sofosbuvir 400 Mg and Velpatasvir 100 Mg Oral Capsules
Queen Mary University of London, Aga Khan University, Dow University of Health Sciences, University of Oxford, University of Bristol
Hepatitis C
09/25
09/25
NCT06605573: Lay User Evaluation of the Panbio™ HCV Self-Test

Not yet recruiting
N/A
1185
NA
Panbio™ HCV Self Test, Fingerstick HIV testing (optional), Laboratory reference testing for HCV (immunoassays and PCR, CE marked)
Abbott Rapid Dx, Aga Khan University, Clinic 553 Karachi, Ezintsha Clinical Research Center
HEPATITIS C (HCV)
03/25
03/25

Download Options